Viewing Study NCT01212757

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:54 PM
Ignite Modification Date: 2026-05-26 @ 11:03 AM
Study NCT ID: NCT01212757
Status: COMPLETED
Last Update Posted: 2020-05-06
First Post: 2010-09-29
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriatic Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Psoriasis View
None Arthritis View
None Psoriatic Arthritis View
None inflammation View
None skin condition View
None inflammatory cells View
None apremilast View
None CC-10004 View
None phosphodiesterase type 4 View